Pharma News

Washington.

TEL AVIV & PARSIPPANY, N.

A drug to halt the progression of Alzheimer’s disease will likely be approved within the next three years, and Alzheon’s ALZ-801 might be the leading candidate.

Drug DevelopmentClarivate published its annual “Drugs to Watch” list, and cited four drugs that it expects to be blockbusters—projected to bring in $1 billion in sales annually.

The U.

A study out of Colombia investigated the effect of ivermectin on symptom duration in the setting of mild COVID-19 infection.

GlaxoSmithKline and partner Vir Biotechnology have seen a key, late-stage test of their experimental COVID-19 drug stopped for new patients amid concerns it may not be working well enough.

CAMBRIDGE, Mass.

A research team is a 3D printing method called stereolithography and jelly-like materials known as hydrogels to develop a 3D printing method that's 10-50 times faster than the industry standard.

After Amgen and AstraZeneca presented positive phase 3 data for their asthma drug candidate tezepelumab, analysts started dissecting how a potential launch could affect other players in the market.

After seeing the biotech's shares soar 300% late last year on positive new data for its midstage gastric cancer program, Amgen has stepped in with a $1.

Texas A&M University College of Medicine ressearchers have recently discovered that cytisine—a smoking cessation drug commonly used in Europe—reduces the loss of dopamine neurons in females.